UK pharmaceutical company Flexipharm Austrading on Monday reported the launch of its second differentiated generic injectable product Methylthioninium Chloride commercially across the UK NHS hospitals.
The company added that Methylthioninium Chloride in 10mg/ml sterile concentrate for solution for injection is the first and only generic licensed medicinal product presentation of methylthioninium chloride to be available in a preferred vial presentation.
Under the MHRA licensed and European Pharmacopoeia compliant product, the generic Methylthioninium Chloride meets or exceeds specifications on levels of organic and metal impurities and has several benefits to the NHS, according to the company.
At the NHS, the generic Methylthioninium Chloride lowers cost and fewer steps to prepare the drug for administration compared to the alternative ampoule product, removes 'sharps' injury risk, often associated with opening ampoules, carries an NHS/List price that is 23% cheaper than the alternative ampoule product, improves shelf life and can be used for up to 24 hours from opening, concluded the company.
Par Pharmaceutical starts shipping colchicine 0.6mg capsules
Padagis launces Brinzolamide Ophthalmic Suspension with CGT exclusivity
Novartis completes Sandoz Spin-off
Novartis completes Sandoz spin-off, focusing on innovative medicines
Hikma marks KLOXXADO two-year anniversary by surpassing 375,000 doses donated in the US
STADA seeks full approval for Kinpeygo in IgA nephropathy from UK MHRA
Azurity Pharmaceuticals completes Slayback Pharma acquisition
Sandoz secures European approval for Tyruko biosimilar in MS treatment
Senores Pharmaceuticals introduces Nicardipine Hydrochloride Capsules USP, 20mg and 30mg in US
Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD foundation
Certara Simcyp receives FDA grants for advanced pharmacokinetic modelling
Sandoz's Tyruko (natalizumab-sztn) gains FDA approval as first biosimilar for relapsing MS
Nephron Pharmaceutical names new chief procurement officer
Lupin Pharmaceuticals launches Tiotropium Bromide Inhalation Powder, 18mcg/capsule in US